Kevin J. Yeaman - 10 Feb 2022 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
President and CEO, Director
Signature
/s/ Daniel Rodriguez, as Attorney-in-Fact for Kevin Yeaman
Issuer symbol
DLB
Transactions as of
10 Feb 2022
Net transactions value
$0
Form type
4
Filing time
11 Feb 2022, 15:19:04 UTC
Previous filing
12 Jan 2022
Next filing
17 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DLB Employee Stock Option (Right to Buy) Gift $0 -91,047 -100% $0.000000* 0 10 Feb 2022 Class A Common Stock 91,047 $91.80 Direct F1, F2
transaction DLB Employee Stock Option (Right to Buy) Gift $0 +91,047 $0.000000 91,047 10 Feb 2022 Class A Common Stock 91,047 $91.80 By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective February 10, 2022 the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes.
F2 This option was granted for a total of 91,047 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2021, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter.